These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 3470162

  • 1. An animal model for evaluation of antigen-specific dialyzable leukocyte extracts therapy of osteosarcoma.
    Tsang KY, Pan JF, Fudenberg HH.
    Clin Immunol Immunopathol; 1987 Mar; 42(3):360-9. PubMed ID: 3470162
    [Abstract] [Full Text] [Related]

  • 2. Transfer of osteosarcoma-specific cell-mediated immunity in hamsters by rabbit dialyzable leukocyte extracts.
    Tsang KY, Fudenberg HH, Pan JF.
    Cell Immunol; 1985 Feb; 90(2):295-302. PubMed ID: 3855389
    [Abstract] [Full Text] [Related]

  • 3. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. 1. Antigen-dependent inhibition and antigen-independent inhibition and enhancement of migration.
    Wilson GB, Fudenberg HH, Horsmanheimo M.
    J Lab Clin Med; 1979 May; 93(5):800-18. PubMed ID: 429876
    [Abstract] [Full Text] [Related]

  • 4. Transfer of cell-mediated immunity to Paracoccidioides brasiliensis in hamsters with dialysable leukocyte extracts.
    Peraçoli MT, Montenegro MR, Soares AM, Mota NG.
    J Med Vet Mycol; 1990 May; 28(1):35-46. PubMed ID: 1694543
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Humoral leukocyte adherence inhibition (H-LAI) follow-up trials on malignant process in mice.
    Kubasova T, Pázmány T, Horváth M, Pál K, Köteles GJ.
    Neoplasma; 1991 May; 38(1):63-8. PubMed ID: 2011211
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Study of the immunopotentiator effects of dialyzable leukocyte extracts obtained out of leukocytes previously used for interferon production.
    Arala-Chaves MP, Porto MT, Kauppinen HL, Massa AA, Myllylä G.
    Vox Sang; 1982 Nov; 43(5):233-42. PubMed ID: 6183830
    [Abstract] [Full Text] [Related]

  • 12. Guidelines for immunotherapy of antigen-specific defects with transfer factor.
    Wilson GB, Fudenberg HH, Keller RH.
    J Clin Lab Immunol; 1984 Feb; 13(2):51-8. PubMed ID: 6202873
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Isoprinosine as an immunopotentiator in an animal model of human osteosarcoma.
    Tsang KY, Fudenberg HH.
    Int J Immunopharmacol; 1981 Feb; 3(4):383-9. PubMed ID: 6174468
    [Abstract] [Full Text] [Related]

  • 15. Dialyzable lymphoid extract (DLE) from mice resistant to STZ-induced diabetogenesis can interrupt the progress of diabetes in STZ-treated CD-1 mice.
    Borkowsky W, Pilson R, Lawrence HS.
    Biotherapy; 1996 Feb; 9(1-3):149-57. PubMed ID: 8993774
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunotherapy with dialyzable leukocyte extracts and studies of their antigen-specific (transfer factor) activity.
    Fudenberg HH, Wilson GB, Smith CL.
    Proc Virchow Pirquet Med Soc; 1980 Dec; 34():3-87. PubMed ID: 6270691
    [No Abstract] [Full Text] [Related]

  • 20. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides.
    Wilson GB, Paddock GV, Fudenberg HH.
    Thymus; 1981 Feb; 2(4-5):257-6. PubMed ID: 6165106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.